Abstract PO1-15-10: Lower pre-treatment B-cell gene expression signatures correspond with improved overall survival with palbociclib + endocrine therapy in HR+/HER2- metastatic breast cancer: a biomarker analysis from the GEICAM/2013-02 PEARL trial
Year: 2024
Type: conference-abstract
Source: Cancer Research
Authors: Yash Agrawal, Aranzazu Fernandez-Martinez, Miguel Gil-Gil, Christoph Zielinski, Manuel Ruíz- Borrego, Eva Ciruelos, Montserrat Muñoz, Mireia Margelí, Begoña Bermejo, Antonio Antón, Zsuzsanna Kahan, Tibor Csöszi, José L Alonso-Romero, Jose Angel García-Sáenz, Pedro Sánchez-Rovira, Elena Álvarez, J. Ignacio Chacón, Santiago González-Santiago, César A Rodríguez, Sonia Servitja, Adam D. Pfefferle, Jesús Herranz, Yuan Liu, Lisa A. Carey, Isabel Romero - Camarero, Rosalía Caballero, Charles M. Perou, Miguel Martín
Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Institut d'Investigació Biomédica de Bellvitge, Institut Català d'Oncologia, GEICAM – Spanish Breast Cancer Group, Wiener Krankenanstaltenverbund, Central European Cooperative Oncology Group, Medical University of Vienna, Hospital Universitario Virgen del Rocío, Hospital Clínic de Barcelona, Universitat de Barcelona, Hospital Clínico Universitario de Valencia, Hospital Universitario Miguel Servet, University of Szeged, Hospital Universitario Virgen de la Arrixaca, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Complejo Hospitalario de Jaén, Hospital Universitario Lucus Augusti, Hospital Universitario de Toledo, Hospital San Pedro de Alcántara, Instituto de Investigación Biomédica de Salamanca, Hospital Del Mar, Hospital General Universitario Gregorio Marañón
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4396590809